<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-07T11:38:29+00:00">
  <iati-activity last-updated-datetime="2026-11-07T09:53:07+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-SLE-Z-WVI-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Global Fund Grant Cycle-7 on HIV/AIDS, Tuberculosis, Malaria and Resilient and Sustainable Systems for Health - Sierra Leone (01-Jul-2024-30-Jun-2027)</narrative>
    </title>
    <description type="1">
      <narrative>Sierra Leone, Multicomponent, World Vision International</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Reduction of new HIV infections; Reduction of AIDs related mortality; Elimination of HIV related stigma and discrimination; TB case detection rate is increased by 15% through active case finding, integration of TB in other services, involvement of Private sector, and expansion of use of Gene-Xpert test, and 90% of Drug Susceptible TB cases notified &amp; treated by 2025; Increase access to laboratory and TB diagnostic services from 50% of the existing Community Health Centers (CHCs) and from 59% of the functional hospitals to 80 % by 2025; Detect and diagnose 90% of the MDR-TB cases and treat with appropriate therapy by 2025; By the end of 2025, contribute significantly to the improvement of the well-being of the population by reducing the malaria burden. Objectives: High Impact Interventions; Three Zeros: Continued guidance by the sustainable development goals (SDGs) as informed by the global UNAIDS 2016-2021 Strategy aimed at eliminating new infections, stigma and AIDS related deaths; The 90-90-90 targets: the at least 90-90-90 (or 95-95-95) targets for the testing and knowledge of sero status; linkages to and enrolment to care and treatment and; retention in treatment and care for the Persons Living with HIV; Differentiated Service Delivery (DSD) and access to effectively reach all the population groups, geographical areas, social strata and navigate the social normative, legal and human rights framework settings and landscape; Conduct active and intensified TB case finding; Build the capacity of HCWs to improve quality of TB care and address districts wide disparities in TB treatment success rate (TSR); Reach TB patients in areas hard to reach areas; By the end of 2025, reduce malaria mortality rates by at least 75% compared to 2015; By the end of 2025, reduce malaria case incidence by at least 75% compared to 2015; By 2025, 90% of the population practice at least 3 recommended malaria prevention and control behaviours; To strengthen malaria surveillance and use of malaria information to improve decision-making for programme performance; Ensure timely and adequate supply of quality-assured malaria commodities to public and private health facilities at all levels by 2025.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="21" role="2" crs-channel-code="21000">
      <narrative>World Vision International</narrative>
    </participating-org>
    <participating-org type="21" role="4" crs-channel-code="21000">
      <narrative>World Vision International</narrative>
    </participating-org>
    <other-identifier ref="SLE-Z-WVIP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2024-07-01" />
    <activity-date type="2" iso-date="2024-07-01" />
    <activity-date type="3" iso-date="2027-06-30" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="SL" percentage="100">
      <narrative>Sierra Leone</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12110" percentage="46.91">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="28.29">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12262" percentage="16.49">
      <narrative>Malaria</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="8.31">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="aecf0171-ec0b-4298-be44-3c2a390d7a69" percentage="0.22">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing for KP programs</narrative>
        </description>
      </budget-item>
      <budget-item code="891c6028-9f9a-427f-8e25-55b502d52054" percentage="0.28">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing outside of KP and AGYW programs</narrative>
        </description>
      </budget-item>
      <budget-item code="e41c9e1f-dfcd-4d62-9a3d-2c6d760bb3af" percentage="0.13">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing for key population (KP) programs</narrative>
        </description>
      </budget-item>
      <budget-item code="26ab57aa-470b-4e99-bff9-92e1452cf6cd" percentage="0.88">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing outside of key population (KP) and adolescent girls and young women (AGYW) programs</narrative>
        </description>
      </budget-item>
      <budget-item code="54f285ef-8db0-40b2-8052-f00a00522b8d" percentage="0.48">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Integrated testing of pregnant women for HIV, syphilis and hepatitis B</narrative>
        </description>
      </budget-item>
      <budget-item code="698ea3f4-346f-4df8-ab2e-c01a47bbccd9" percentage="1.6">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Prevention of incident HIV among pregnant and breastfeeding women</narrative>
        </description>
      </budget-item>
      <budget-item code="92423e34-c66c-47f4-9cac-58b9e0ea01fc" percentage="0.09">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Community empowerment for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="7a803e07-8560-47f6-9b59-72193d6812db" percentage="0.23">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Condom and lubricant programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="86dc2898-1dfb-4559-a4cb-72cd5a2cd403" percentage="7.11">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; HIV prevention communication, information and demand creation for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="7300b0bf-fc7f-49ac-b933-534346c226a5" percentage="1.46">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="97e87d65-a4de-4357-81ae-2aae27b112a2" percentage="0.89">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; HIV prevention communication, information and demand creation for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="a120a70d-52df-43de-97e1-765d63db4170" percentage="0.11">
        <description>
          <narrative>HIV -&gt; Prevention package for people in prisons and other closed settings -&gt; HIV prevention communication, information and demand creation for prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="f1547d57-4fe3-48f6-acd2-f3c9e4e016d1" percentage="0.14">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Needle and syringe programs for PWID</narrative>
        </description>
      </budget-item>
      <budget-item code="49ef45b6-ef30-48b1-b393-f34c25d513c4" percentage="0.38">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Opioid substitution therapy and other medically assisted drug dependence treatment for PWID</narrative>
        </description>
      </budget-item>
      <budget-item code="12d964e1-5c4b-4caa-9b00-225bb89861dd" percentage="0.16">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Community empowerment for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="394d6538-8808-4811-b96b-d6bf71843cb6" percentage="2.01">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; HIV prevention communication, information and demand creation for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="4ad468bf-4376-466e-944a-b25f3e1b00ee" percentage="0.71">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="6853dd18-909c-4836-8981-2e434afc456c" percentage="0.09">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="e6662a80-0f0d-4611-990c-6044696834dc" percentage="0.13">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Community mobilization and advocacy for human rights</narrative>
        </description>
      </budget-item>
      <budget-item code="9bcc0e33-1356-4897-a1b3-d9171e326a60" percentage="4.01">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Eliminating stigma and discrimination in all settings</narrative>
        </description>
      </budget-item>
      <budget-item code="39d71dad-c8af-467d-9fcc-8ac534b86784" percentage="1.46">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Ensuring nondiscriminatory provision of health care</narrative>
        </description>
      </budget-item>
      <budget-item code="10e03ea0-16be-40e1-9fba-682edec921d0" percentage="0.79">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Ensuring rights-based law enforcement practices</narrative>
        </description>
      </budget-item>
      <budget-item code="b745fdfb-055f-428b-9634-646cf15f5904" percentage="0.78">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Improving laws, regulations and policies relating to HIV and HIV/TB</narrative>
        </description>
      </budget-item>
      <budget-item code="28c1900d-472f-4af5-94d7-2b92f93ab743" percentage="0.8">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Increasing access to justice (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="ecc245de-32bf-41ff-8eb1-f5fae2eb1557" percentage="0.86">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Legal literacy ("Know Your Rights") (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="e0bd4666-bd16-440a-81d4-ded76d1d1b10" percentage="0.77">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity</narrative>
        </description>
      </budget-item>
      <budget-item code="d49b353e-9087-48e0-9c3b-f8ed91d6fd53" percentage="0.03">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - adults (15 and above)</narrative>
        </description>
      </budget-item>
      <budget-item code="6bb2376e-8c74-4cf1-98f0-f72ea58797fa" percentage="0.53">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - children (under 15)</narrative>
        </description>
      </budget-item>
      <budget-item code="423a40f4-4716-48a1-9c6c-7b78ede223af" percentage="1.17">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Integrated management of common co-infections and co-morbidities (adults and children)</narrative>
        </description>
      </budget-item>
      <budget-item code="f4134963-9477-4972-86b5-4a0048ce0063" percentage="4.73">
        <description>
          <narrative>Malaria -&gt; Specific prevention interventions (SPI) -&gt; Social and behavior change (SBC) (Specific prevention interventions)</narrative>
        </description>
      </budget-item>
      <budget-item code="0904e74b-3fd7-4544-bb4e-8343228bdbe5" percentage="11.76">
        <description>
          <narrative>Malaria -&gt; Vector control -&gt; Insecticide treated nets (ITNs) - Mass campaign: universal</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="33.27">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="5a6fc5ba-08a3-455c-887d-00867a865303" percentage="0.02">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Human resources for health (HRH) and quality of care -&gt; RSSH/PP: Quality improvement and capacity building for quality of care</narrative>
        </description>
      </budget-item>
      <budget-item code="0aa54232-09ea-488b-86df-48a82af99ed4" percentage="0.16">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Quality management systems and accreditation</narrative>
        </description>
      </budget-item>
      <budget-item code="db62704e-5b08-4eb1-b5cb-39a697705c19" percentage="0.76">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Capacity building and leadership development</narrative>
        </description>
      </budget-item>
      <budget-item code="7dbf6454-4357-4937-89a1-9a1c7f0174fa" percentage="1.12">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community engagement, linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="8c042996-0cb7-4540-ad17-483cf18ec784" percentage="2.14">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led monitoring</narrative>
        </description>
      </budget-item>
      <budget-item code="12d82614-1fc1-4696-b954-b899115b31d9" percentage="0.2">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led research and advocacy</narrative>
        </description>
      </budget-item>
      <budget-item code="48d7f7e3-61fc-4c8d-88f3-aefc44da79dc" percentage="0.27">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Planning and procurement capacity</narrative>
        </description>
      </budget-item>
      <budget-item code="1e7328c2-4fcd-47b0-8e3c-31a8a421d74c" percentage="0.02">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Regulatory/quality assurance support</narrative>
        </description>
      </budget-item>
      <budget-item code="31d3a0e8-e9f1-4c88-b1b7-ce75b4e952eb" percentage="7.3">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Storage and distribution capacity, design &amp; operations</narrative>
        </description>
      </budget-item>
      <budget-item code="38ed2119-0193-4f73-9333-90fbd5a8cc0b" percentage="1.64">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Supply chain information systems</narrative>
        </description>
      </budget-item>
      <budget-item code="95211519-fdf1-4ae4-964d-27e8afa798cf" percentage="0.04">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Community-based TB/DR-TB care</narrative>
        </description>
      </budget-item>
      <budget-item code="ea39b4f6-cd94-4310-b181-394f794f9144" percentage="0.19">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB diagnosis/drug susceptibility testing (DST)</narrative>
        </description>
      </budget-item>
      <budget-item code="5b20da70-c625-405c-858b-6de52626ae46" percentage="2.88">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="f50f08b4-b9d9-4b4a-a8b2-065858f9ce31" percentage="4.99">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="003bd5ec-d813-43cd-9bae-ec060870a2c4" percentage="0.15">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="8f363382-1b81-4d2d-a396-2be1435016f2" percentage="0.06">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">2141217.20</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">8572949.78</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">9686222.88</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2027-01-01" />
      <period-end iso-date="2027-12-31" />
      <value currency="USD" value-date="2027-01-01">3537075.70</value>
    </budget>
    <capital-spend percentage="7.32" />
    <transaction ref="910f3d17-1859-43c2-ab5a-d93b63f776e3">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-06-29" />
      <value currency="USD" value-date="2024-06-29">12175628.76</value>
      <description>
        <narrative>Global Fund commitment to SLE-Z-WVIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="63b520fe-166f-4ecc-a88d-02812a5139e4">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-07-02" />
      <value currency="USD" value-date="2024-07-02">2252070.00</value>
      <description>
        <narrative>Global Fund disbursement to SLE-Z-WVIP01 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9c089ac9-0b1a-4328-a835-fd02be9a441b">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-07" />
      <value currency="USD" value-date="2024-11-07">2381898.00</value>
      <description>
        <narrative>Global Fund disbursement to SLE-Z-WVIP01 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="895dc875-392a-42a3-bdd8-43e561b57e6f">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-13" />
      <value currency="USD" value-date="2025-03-13">874157.00</value>
      <description>
        <narrative>Global Fund disbursement to SLE-Z-WVIP01 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d82a5c70-78ef-44c4-857e-5224ee1d8e58">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-22" />
      <value currency="USD" value-date="2025-07-22">2017234.00</value>
      <description>
        <narrative>Global Fund disbursement to SLE-Z-WVIP01 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e2b41682-fdba-4718-a415-990dc63c2487">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-18" />
      <value currency="USD" value-date="2025-11-18">1874668.00</value>
      <description>
        <narrative>Global Fund disbursement to SLE-Z-WVIP01 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a41b5407-d851-4f95-b379-fc2f892eb94c">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-02-10" />
      <value currency="USD" value-date="2026-02-10">1569708.02</value>
      <description>
        <narrative>Global Fund disbursement to SLE-Z-WVIP01 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="20e04b8c-e100-460a-913d-8703166ac5f8">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-20" />
      <value currency="USD" value-date="2026-04-20">-1205893.74</value>
      <description>
        <narrative>Global Fund commitment to SLE-Z-WVIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="df9e5b53-bd64-464b-bf84-61b1777dbd48">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-20" />
      <value currency="USD" value-date="2026-04-20">0.00</value>
      <description>
        <narrative>Global Fund commitment to SLE-Z-WVIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e67b551d-babe-4d7d-95ef-82eb31a108cb">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-27" />
      <value currency="USD" value-date="2026-06-27">10566744.77</value>
      <description>
        <narrative>Global Fund commitment to SLE-Z-WVIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c57ca34d-4bb6-4573-af06-e7f2299b2528">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-01" />
      <value currency="USD" value-date="2026-07-01">806122.65</value>
      <description>
        <narrative>Global Fund disbursement to SLE-Z-WVIP01 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="96c5a183-3801-4b63-873f-d085a3ccb261">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-06" />
      <value currency="USD" value-date="2026-10-06">1267436.34</value>
      <description>
        <narrative>Global Fund disbursement to SLE-Z-WVIP01 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="SLE-Z-WVIP01-EXP-20241231">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">2141217.00</value>
      <description>
        <narrative>Expenditure reported by World Vision International for SLE-Z-WVIP01, Jul 2024 to Dec 2024.</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
    </transaction>
    <transaction ref="SLE-Z-WVIP01-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">6710292.71</value>
      <description>
        <narrative>Expenditure reported by World Vision International for SLE-Z-WVIP01, Jan 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/SLE-Z-WVI" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-07" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="27.79">
          <comment>
            <narrative>Numerator: 5557; Denominator: 20000.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="7">
            <comment>
              <narrative>Numerator: 1548; Denominator: 22114.</narrative>
            </comment>
          </target>
          <actual value="10.26">
            <comment>
              <narrative>Numerator: 2269; Denominator: 22114.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="7">
            <comment>
              <narrative>Numerator: 1548; Denominator: 22114.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="9.4">
            <comment>
              <narrative>Numerator: 2010; Denominator: 21496.</narrative>
            </comment>
          </target>
          <actual value="25.71">
            <comment>
              <narrative>Numerator: 5526; Denominator: 21496.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="9.35">
            <comment>
              <narrative>Numerator: 2010; Denominator: 21496.</narrative>
            </comment>
          </target>
          <actual value="25.71">
            <comment>
              <narrative>Numerator: 5526; Denominator: 21496.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="9.35">
            <comment>
              <narrative>Numerator: 2010; Denominator: 21496.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="12">
            <comment>
              <narrative>Numerator: 3018; Denominator: 25150.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target value="12">
            <comment>
              <narrative>Numerator: 3018; Denominator: 25150.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="61.53">
          <comment>
            <narrative>Numerator: 1046; Denominator: 1700.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="6">
            <comment>
              <narrative>Numerator: 591; Denominator: 9850.</narrative>
            </comment>
          </target>
          <actual value="29.12">
            <comment>
              <narrative>Numerator: 2868; Denominator: 9850.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="8.5">
            <comment>
              <narrative>Numerator: 822; Denominator: 9619.</narrative>
            </comment>
          </target>
          <actual value="62.72">
            <comment>
              <narrative>Numerator: 6106; Denominator: 9736.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="6">
            <comment>
              <narrative>Numerator: 591; Denominator: 9850.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="8.55">
            <comment>
              <narrative>Numerator: 822; Denominator: 9619.</narrative>
            </comment>
          </target>
          <actual value="62.72">
            <comment>
              <narrative>Numerator: 6106; Denominator: 9736.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="8.55">
            <comment>
              <narrative>Numerator: 822; Denominator: 9619.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="8.55">
            <comment>
              <narrative>Numerator: 986; Denominator: 11532.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target value="12">
            <comment>
              <narrative>Numerator: 1346; Denominator: 11217.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="17.02">
          <comment>
            <narrative>Numerator: 40839; Denominator: 240000.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="25">
            <comment>
              <narrative>Numerator: 9888; Denominator: 39552.</narrative>
            </comment>
          </target>
          <actual value="25.53">
            <comment>
              <narrative>Numerator: 10099; Denominator: 39552.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="35">
            <comment>
              <narrative>Numerator: 13843; Denominator: 39549.</narrative>
            </comment>
          </target>
          <actual value="42.39">
            <comment>
              <narrative>Numerator: 16763; Denominator: 39549.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="25">
            <comment>
              <narrative>Numerator: 9888; Denominator: 39552.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="35">
            <comment>
              <narrative>Numerator: 13843; Denominator: 39549.</narrative>
            </comment>
          </target>
          <actual value="42.39">
            <comment>
              <narrative>Numerator: 16763; Denominator: 39549.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="35">
            <comment>
              <narrative>Numerator: 13843; Denominator: 39549.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="40">
            <comment>
              <narrative>Numerator: 18984; Denominator: 47460.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target value="40">
            <comment>
              <narrative>Numerator: 18984; Denominator: 47460.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for men who have sex with men (MSM) and their sexual partners.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="64.68">
          <comment>
            <narrative>Numerator: 12936; Denominator: 20000.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="16">
            <comment>
              <narrative>Numerator: 3439; Denominator: 21494.</narrative>
            </comment>
          </target>
          <actual value="10.56">
            <comment>
              <narrative>Numerator: 2270; Denominator: 21494.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="17">
            <comment>
              <narrative>Numerator: 3654; Denominator: 21494.</narrative>
            </comment>
          </target>
          <actual value="28.68">
            <comment>
              <narrative>Numerator: 6164; Denominator: 21494.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="16">
            <comment>
              <narrative>Numerator: 3439; Denominator: 21494.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="17">
            <comment>
              <narrative>Numerator: 3654; Denominator: 21494.</narrative>
            </comment>
          </target>
          <actual value="28.68">
            <comment>
              <narrative>Numerator: 6164; Denominator: 21494.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="17">
            <comment>
              <narrative>Numerator: 3654; Denominator: 21494.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="18">
            <comment>
              <narrative>Numerator: 4643; Denominator: 25794.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target value="18">
            <comment>
              <narrative>Numerator: 4643; Denominator: 25794.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for people who use drugs (PUD) and their sexual partners.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="66.09">
          <comment>
            <narrative>Numerator: 1156; Denominator: 1749.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="26">
            <comment>
              <narrative>Numerator: 2492; Denominator: 9585.</narrative>
            </comment>
          </target>
          <actual value="26.19">
            <comment>
              <narrative>Numerator: 2510; Denominator: 9585.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="26">
            <comment>
              <narrative>Numerator: 2492; Denominator: 9585.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="33">
            <comment>
              <narrative>Numerator: 3213; Denominator: 9736.</narrative>
            </comment>
          </target>
          <actual value="69.3">
            <comment>
              <narrative>Numerator: 6747; Denominator: 9736.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="33">
            <comment>
              <narrative>Numerator: 3213; Denominator: 9736.</narrative>
            </comment>
          </target>
          <actual value="69.3">
            <comment>
              <narrative>Numerator: 6747; Denominator: 9736.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="33">
            <comment>
              <narrative>Numerator: 3213; Denominator: 9736.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="41">
            <comment>
              <narrative>Numerator: 4721; Denominator: 11515.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target value="41">
            <comment>
              <narrative>Numerator: 4721; Denominator: 11515.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for sex workers, their clients and other sexual partners.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="39.7">
          <comment>
            <narrative>Numerator: 95283; Denominator: 240000.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="41">
            <comment>
              <narrative>Numerator: 16373; Denominator: 39934.</narrative>
            </comment>
          </target>
          <actual value="27.81">
            <comment>
              <narrative>Numerator: 11106; Denominator: 39934.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="41">
            <comment>
              <narrative>Numerator: 16373; Denominator: 39934.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="42.2">
            <comment>
              <narrative>Numerator: 16690; Denominator: 39549.</narrative>
            </comment>
          </target>
          <actual value="58.09">
            <comment>
              <narrative>Numerator: 22973; Denominator: 39549.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="42.2">
            <comment>
              <narrative>Numerator: 16690; Denominator: 39549.</narrative>
            </comment>
          </target>
          <actual value="58.09">
            <comment>
              <narrative>Numerator: 22973; Denominator: 39549.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="42.2">
            <comment>
              <narrative>Numerator: 16690; Denominator: 39549.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="43">
            <comment>
              <narrative>Numerator: 20435; Denominator: 47523.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target value="43">
            <comment>
              <narrative>Numerator: 20435; Denominator: 47523.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>